In-Vitro Toxicology/Toxicity Testing Market

In-Vitro Toxicology/Toxicity Testing Market by Product & Services, Toxicity Endpoint & Test (Carcinogenicity, Dermal Toxicity), Technology (Cell-based, HTS), Method (Cellular Assays), Industry (Pharmaceutical, Cosmetics), Region-Global Forecast to 2024

Report Code: BT 2373 Sep, 2019, by marketsandmarkets.com

[253 Pages Report] The global in vitro toxicology testing market is projected to reach USD 12.7 billion by 2024 from USD 8.1 billion in 2019, at a CAGR of 9.3%. Growth in this market is driven majorly by the opposition to animal testing, technological advancements, and increasing R&D expenditure to detect toxicity at an early stage during drug development.

In Vitro Toxicity Testing Market, by Region, 2022 (USD Billion)

The consumables segment is expected to account for the largest share of the in-vitro toxicology testing market in 2018

Consumables are expected to be the largest revenue contributor to the in-vitro toxicology testing market in 2018. The large share of this segment can be attributed to the increasing demand for high-quality reagents and the repeated use of media and reagents in in-vitro toxicology studies.

The organ toxicity segment is expected to grow at a high CAGR

The toxicity endpoints & tests market includes ADME; skin irritation, corrosion, and sensitization; genotoxicity; cytotoxicity; ocular toxicity; organ toxicity; phototoxicity; dermal toxicity; and other toxicity endpoints & tests. The organ toxicity segment is expected to grow at the highest CAGR during the forecast period due to factors such as the increasing focus on drug safety and consumer-product safety, along with the need to screen potential drug targets during the early stage of drug development.

The cell culture segment is expected to account for the largest share of the in-vitro toxicology technologies market in 2018

The cell culture segment accounted for the largest share of the market in 2018. This is attributed to the fact that it is the most preferred technique for toxicity testing, being capable of mimicking in vivo conditions. Also, cell culture technologies are used widely in laboratories where primary cultures and basal cells help decipher the basic toxicity screening of substances under study. They are affordable and easy to use as compared to other technologies, which has contributed significantly to their adoption.

In Vitro Toxicity Testing Market, by Region, 2022 (USD Billion)

Asia Pacific is expected to grow at the highest rate in the in-vitro toxicology testing market

The in-vitro toxicology testing market in the Asia Pacific is estimated to grow at the highest CAGR during the forecast period. This is due to the emergence of CROs for outsourcing toxicology-related research projects, opposition to animal testing resulting in the use of alternate methods, increasing pharmaceutical drug pipeline, and growing consumer awareness of product safety, all of which are driving adoption of in-vitro toxicology testing in Asia Pacific.

Key Market Players

The prominent players in the in-vitro toxicology testing market include Thermo Fisher Scientific Inc. (US), Covance (US), Bio-Rad Laboratories, Inc. (US), GE Healthcare (US), Eurofins Scientific SE (Luxembourg), Merck KGaA (Germany), Charles River Laboratories International, Inc. (US), Catalent, Inc. (US), Cyprotex (UK), SGS S.A. (Switzerland), QIAGEN N.V. (Germany), Promega Corporation (US), Gentronix Limited (UK), BioIVT (US), and MB Research Laboratories (US).

Thermo Fisher Scientific, Inc.  (US)

Thermo Fisher Scientific was one of the leading players in the in-vitro toxicology testing market in 2018. The company is a global manufacturer of analytical instruments, laboratory equipment, software, consumables, reagents, and services for the in-vitro toxicology testing market. With a strong global presence, Thermo Fisher Scientific is continuously involved in product and technological innovations for the proteomics market, which has led to an increase in the company’s overall revenue. It focuses on acquiring new consumers through expansions, partnerships, and collaborations in emerging markets like China, India, and South Korea. Over the last three years, the company has also focused on bringing technologically advanced instruments to the market to enhance research capabilities. The company can also explore strategic agreements with academic institutions, as these institutions conduct research studies that make use of in-vitro techniques

Merck KGaA (Germany)

Merck is a leading science and technology company with a strong global presence in more than 120 countries. The company has a portfolio of more than 300,000 life science products that support a broad customer base. Merck majorly focuses on expansions in key geographies to increase its customer base. The firm focuses explicitly on the high-growth Asia Pacific region to increase its market share and revenue. In the last three years, the firm opened life science centers in China, India, South Korea, and Singapore to facilitate the supply of its products in the region. Targeted acquisitions to complement or boost its strengths form another key strategy for the company.

Scope of the Report:

Report Metric

Details

Market size available for years

2017–2024

Base year considered

2018

Forecast period

2019–2024

Forecast units

Value (USD)

Segments covered

Product & Service, Technology, Toxicity Endpoint & Test, Industry, Method, and Region

Geographies covered

North America, Europe, APAC, Latin America, and the Middle East & Africa

Companies covered

Thermo Fisher Scientific Inc. (US), Covance (US), Bio-Rad Laboratories, Inc. (US), GE Healthcare (US), Eurofins Scientific SE (Luxembourg), Merck KGaA (Germany), Charles River Laboratories International, Inc. (US), Catalent, Inc. (US), Cyprotex (UK), SGS S.A. (Switzerland), QIAGEN N.V. (Germany), Promega Corporation (US), Gentronix Limited (UK), BioIVT (US), and MB Research Laboratories (US)

The research report categorizes the market into the following segments and subsegments:

By Product & Service

  • Consumables
  • Assays
    • Bacterial Toxicity Assays
    • Enzyme Toxicity Assays
    • Cell-based Elisa & Western Blots
    • Receptor-binding Assays
    • Tissue Culture Assays
    • Other Assays
  • Equipment
  • Software
  • Services

By Method

  • Cellular Assays 
  • Biochemical Assays
  • In Silico Models
  • Ex Vivo Models

By Toxicity Endpoint

  • ADME
  • Skin Irritation, Corrosion, & Sensitization
  • Genotoxicity Testing
  • Cytotoxicity Testing
  • Ocular Toxicity
  • Organ Toxicity
  • Phototoxicity Testing
  • Dermal Toxicity
  • Other Toxicity Endpoints & Tests

By Technology

  • Cell Culture Technologies 
  • High-throughput Technologies 
  • Toxicogenomics

By Industry

  • Pharmaceuticals & Biopharmaceuticals
  • Cosmetic & Household Products
  • Food
  • Chemicals

By Region

  • North America
    • US
    • Canada
  • Europe
    • Germany
    • UK
    • France
    • Italy
    • Spain
    • Rest of Europe
  • Asia Pacific
    • China
    • India
    • Japan
    • Rest of APAC
  • Latin America
  • Middle East & Africa

Critical questions the report answers:

  • Where will all these developments take the industry in the medium to long-term?
  • Which are the major types of products offered in in-vitro toxicology testing?
  • Which geographies are likely to grow at the highest CAGR?
  • Which are the major industries for in-vitro toxicology testing market?
  • What are the research areas of the in-vitro toxicology testing market?

To speak to our analyst for a discussion on the above findings, click Speak to Analyst

Table of Contents

1 Introduction (Page No. - 22)
    1.1 Objectives of the Study
    1.2 Market Definition
    1.3 Market Scope
           1.3.1 Markets Covered
           1.3.2 Years Considered for the Study
    1.4 Currency
    1.5 Stakeholders
    1.6 Limitations

2 Research Methodology (Page No. - 26)
    2.1 Research Approach
           2.1.1 Secondary Research
                    2.1.1.1 Key Data From Secondary Sources
           2.1.2 Primary Research
                    2.1.2.1 Key Data From Primary Sources
                    2.1.2.2 Breakdown of Primaries
    2.2 Market Size Estimation
    2.3 Data Triangulation Approach
    2.4 Market Share Estimation
    2.5 Assumptions for the Study

3 Executive Summary (Page No. - 34)

4 Premium Insights (Page No. - 39)
    4.1 In Vitro Toxicology Testing Market Overview
    4.2 Asia Pacific: In Vitro Toxicology Testing Market, By Method
    4.3 In Vitro Toxicology Testing Market: Geographic Growth Opportunities
    4.4 In Vitro Toxicology Testing Market, By Region (2017–2024)
    4.5 In Vitro Toxicology Testing Market: Developed vs Developing Markets

5 Market Overview (Page No. - 44)
    5.1 Introduction
    5.2 Market Dynamics
           5.2.1 Market Drivers
                    5.2.1.1 Opposition to Animal Testing
                    5.2.1.2 Technological Advancements
                    5.2.1.3 R&D on Early-Stage Toxicity Detection
           5.2.2 Market Restraints
                    5.2.2.1 Reluctance of Regulatory Authorities to Consider Alternative Methods for Proving Safety and Efficacy
                    5.2.2.2 Failure to Establish the Intricacies of in Vivo Conditions
                    5.2.2.3 Lack of In Vitro Models to Study Complex Endpoints
           5.2.3 Market Opportunities
                    5.2.3.1 Increasing Focus on Drug Discovery and Personalized Medicine Using In Vitro Methods
                    5.2.3.2 Increasing Number of Toxicology Databases
           5.2.4 Market Challenges
                    5.2.4.1 Dearth of Skilled Professionals

6 Industry Insights (Page No. - 51)
    6.1 Introduction
    6.2 Industry Trends
           6.2.1 Increasing Focus on Predictive Toxicology
    6.3 Supply Chain Analysis
    6.4 Regulatory Committee Activities
           6.4.1 Major Stakeholders
           6.4.2 Key Influencers

7 In Vitro Toxicology Testing Market, By Product & Service (Page No. - 55)
    7.1 Introduction
    7.2 Consumables
           7.2.1 Consumables to Dominate the In Vitro Toxicology Testing Market During the Forecast Period
    7.3 Assays
           7.3.1 Bacterial Toxicity Assays
                    7.3.1.1 Bacterial Assays Dominate the Market as They are the Most Widely Adopted Assay Type Across Industries
           7.3.2 Enzyme Toxicity Assays
                    7.3.2.1 Enzyme Toxicity Assays are Increasingly Used for Endocrine-Disrupting Studies—A Key Factor Driving Market Growth
           7.3.3 Cell-Based Elisa & Western Blots
                    7.3.3.1 Cell-Based Assays are Cost-Effective, Owing to Which They are Witnessing Increasing Adoption in Drug Discovery
           7.3.4 Receptor-Binding Assays
                    7.3.4.1 Receptor-Binding Assays are Well-Suited for High-Throughput Formats, A Key Factor Driving the Adoption of These Products
           7.3.5 Tissue Culture Assays
                    7.3.5.1 Tissue Culture Assays Offer the Advantage of Mimicking in Vivo Tissue Architecture
           7.3.6 Other Assays
    7.4 Equipment
           7.4.1 Fully Automated Equipment is Witnessing Growing Adoption in Research
    7.5 Software
           7.5.1 Software Tools are Vital in Reducing Analysis Times and Managing Large Amounts of Data Generated in Operations
    7.6 Services
           7.6.1 Lack of Infrastructure and Expertise have Driven Reliance on Service Providers

8 In Vitro Toxicology Testing Market, By Toxicity Endpoint & Test (Page No. - 71)
    8.1 Introduction
    8.2 Adme (Absorption, Distribution, Metabolism, & Excretion) Testing
           8.2.1 Adme Testing to Dominate the In Vitro Toxicology Testing Market During the Forecast Period
    8.3 Skin Irritation, Corrosion, & Sensitization Testing
           8.3.1 Skin Irritation, Corrosion, and Sensitization are Major Endpoints Studied in the Cosmetics Industry
    8.4 Genotoxicity Testing
           8.4.1 More Genotoxicity Tests are Reviewed and Validated By Regulatory Authorities Than Any Other Endpoint—A Key Driver for Market Growth
    8.5 Cytotoxicity Testing
           8.5.1 Rising Need for Biosafety is Largely Contributing to the Growth of the Cytotoxicity Testing Market
    8.6 Ocular Toxicity Testing
           8.6.1 In Vitro and EX Vivo Methods are Gaining High Recognition for Ocular Toxicity Testing
    8.7 Organ Toxicity Testing
           8.7.1 High-Content Screening and Cell-Based Assays are Used to Detect Organ-Specific Toxicity
    8.8 Phototoxicity Testing
           8.8.1 Validated Non-Animal Methods are Used to Evaluate the Photosafety of Cosmetics, Pharmaceuticals, & Chemicals
    8.9 Dermal Toxicity Testing
           8.9.1 In Vitro Methods for Dermal Toxicity Testing are Expected to Gain Recognition in the Coming Years
    8.10 Other Toxicity Endpoints & Tests

9 In Vitro Toxicology Testing Market, By Technology (Page No. - 85)
    9.1 Introduction
    9.2 Cell Culture Technologies
           9.2.1 Cell- & Tissue-Based Technologies are the Most Widely Adopted in In Vitro Testing
    9.3 High-Throughput Technologies
           9.3.1 Increasing Use of High-Content Imaging Technologies is Driving Market Growth
    9.4 Toxicogenomics
           9.4.1 Improvements in Proteomic Technologies are Enhancing the Study of Gene & Protein Activity During Toxicity Analysis

10 In Vitro Toxicology Testing Market, By Industry (Page No. - 92)
     10.1 Introduction
     10.2 Pharmaceuticals & Biopharmaceuticals
             10.2.1 Drug Attrition Rate is Leading to the High Adoption of In Vitro Testing Assays in the Early Stages of Drug Development
     10.3 Cosmetics & Household Products
             10.3.1 Ban on Animal Testing is Increasing the Adoption of In Vitro Assays for Safety Testing
     10.4 Food
             10.4.1 Increasing Focus on Food Safety is Driving Market Growth
     10.5 Chemicals
             10.5.1 Increasing Focus on Organoid-Based In Vitro Approaches for Chemical Testing is Propelling the Market

11 In Vitro Toxicology Testing Market, By Method (Page No. - 101)
     11.1 Introduction
     11.2 Cellular Assays
             11.2.1 Development of Multi-Parameter Assays Will Provide Significant Growth Opportunities to Market Players
     11.3 Biochemical Assays
             11.3.1 Biochemical Assays Find Wider Application in the Pharmaceutical Industry as Compared to the Chemical and Food Industries
     11.4 in Silico Models
             11.4.1 in Silico Models are Expected to Register the Highest CAGR During the Forecast Period
     11.5 EX Vivo Models
             11.5.1 EX Vivo Models are Widely Used in Skin & Eye Toxicity Testing in the Cosmetic Industry

12 In Vitro Toxicology Testing Market, By Region (Page No. - 108)
     12.1 Introduction
     12.2 Europe
             12.2.1 Germany
                        12.2.1.1 Germany Holds the Largest Share of the European Market
             12.2.2 UK
                        12.2.2.1 Rising Awareness, Growing R&D, and Increasing Collaborations are Key Indicators of Market Growth in the UK
             12.2.3 France
                        12.2.3.1 Research Initiatives Supported By the Government are Aiding Market Growth in France
             12.2.4 Italy
                        12.2.4.1 Growth in This Market is Mainly Driven By the Increasing Life Science R&D
             12.2.5 Spain
                        12.2.5.1 Spain’s Growing Chemical Industry is A Major Factor Supporting the In Vitro Toxicology Testing Market in the Country
             12.2.6 Rest of Europe
     12.3 North America
             12.3.1 US
                        12.3.1.1 The US Dominates the North American In Vitro Toxicology Testing Market Due to A Growing Focus on Biomarker Discovery and Research in the Field of Structure-Based Drug Design
             12.3.2 Canada
                        12.3.2.1 Strong Support for R&D and Focus on Developing New Therapies Will Support Market Growth in Canada
     12.4 Asia Pacific
             12.4.1 China
                        12.4.1.1 Increasing International Pressure to Ban Animal Testing Methods Will Propel Market Growth in the Coming Years
             12.4.2 Japan
                        12.4.2.1 Use of Artificial Skin Patches and Plates of Cultured Human Cells has Increased in Japan
             12.4.3 India
                        12.4.3.1 Growing Crams Industry and the Ban on the Use of Animals in Cosmetics and Universities are Likely to Propel Market Growth
             12.4.4 Rest of Asia Pacific
     12.5 Latin America
             12.5.1 Low Cost of Drug Trials have Made Latin America A Popular Outsourcing Market
     12.6 Middle East & Africa
             12.6.1 Increasing R&D Investments and Focus on the Development of New Drugs are Contributing to Market Growth

13 Competitive Landscape (Page No. - 173)
     13.1 Overview
     13.2 Market Share Analysis
     13.3 Competitive Leadership Mapping
             13.3.1 Visionary Leaders
             13.3.2 Innovators
             13.3.3 Dynamic Differentiators
             13.3.4 Emerging Companies
     13.4 Competitive Situation and Trends
             13.4.1 Product & Service Launches
             13.4.2 Expansions
             13.4.3 Acquisitions
             13.4.4 Other Strategies

14 Company Profiles (Page No. - 183)
(Business Overview, Products Offered, Recent Developments, MnM View)*
     14.1 Thermo Fisher Scientific, Inc.
     14.2 Merck KGaA
     14.3 Eurofins Scientific Se
     14.4 GE Healthcare
     14.5 Covance, Inc.
     14.6 Charles River Laboratories International, Inc.
     14.7 SGS S.A.
     14.8 Bio-Rad Laboratories, Inc.
     14.9 Qiagen N.V.
     14.10 Cyprotex PLC
     14.11 Promega Corporation
     14.12 Catalent, Inc.
     14.13 Gentronix Limited
     14.14 Mb Research Laboratories
     14.15 Bioivt
     14.16 Creative Biolabs
     14.17 GVK Biosciences Private Limited
     14.18 Shanghai Medicilon Inc.
     14.19 Creative Bioarray
     14.20 Insphero

*Business Overview, Products Offered, Recent Developments, MnM View Might Not Be Captured in Case of Unlisted Companies.

15 Appendix (Page No. - 243)
     15.1 Insights of Industry Experts
     15.2 Discussion Guide
     15.3 Knowledge Store: Marketsandmarkets’ Subscription Portal
     15.4 Available Customizations
     15.5 Related Reports
     15.6 Author Details


List of Tables (148 Tables)

Table 1 In Vitro Toxicology Testing Market, By Product & Service, 2017–2024 (USD Million)
Table 2 In Vitro Toxicology Testing Consumables Market, By Country, 2017–2024 (USD Million)
Table 3 In Vitro Toxicology Testing Assays Market, By Type, 2017–2024 (USD Million)
Table 4 In Vitro Toxicology Testing Assays Market, By Country, 2017–2024 (USD Million)
Table 5 Bacterial Toxicity Assays Market, By Country, 2017–2024 (USD Million)
Table 6 Enzyme Toxicity Assays Market, By Country, 2017–2024 (USD Million)
Table 7 Cell-Based Elisa & Western Blots Market, By Country, 2017–2024 (USD Million)
Table 8 Receptor-Binding Assays Market, By Country, 2017–2024 (USD Million)
Table 9 Tissue Culture Assays Market, By Country, 2017–2024 (USD Million)
Table 10 Other Assays Market, By Country, 2017–2024 (USD Million)
Table 11 In Vitro Toxicology Testing Equipment Market, By Country, 2017–2024 (USD Million)
Table 12 In Vitro Toxicology Testing Software Market, By Country, 2017–2024 (USD Million)
Table 13 In Vitro Toxicology Testing Services Market, By Country, 2017–2024 (USD Million)
Table 14 In Vitro Toxicology Testing Market, By Toxicity Endpoint & Test, 2017–2024 (USD Million)
Table 15 Adme Testing Market, By Country, 2017–2024 (USD Million)
Table 16 Skin Irritation, Corrosion, & Sensitization Testing Market, By Country, 2017–2024 (USD Million)
Table 17 Genotoxicity Testing Market, By Country, 2017–2024 (USD Million)
Table 18 Cytotoxicity Testing Market, By Country, 2017–2024 (USD Million)
Table 19 Ocular Toxicity Testing Market, By Country, 2017–2024 (USD Million)
Table 20 Organ Toxicity Testing Market, By Country, 2017–2024 (USD Million)
Table 21 Phototoxicity Testing Market, By Country, 2017–2024 (USD Million)
Table 22 Dermal Toxicity Testing Market, By Country, 2017–2024 (USD Million)
Table 23 Other Toxicity Endpoints & Tests Market, By Country, 2017–2024 (USD Million)
Table 24 In Vitro Toxicology Testing Market, By Technology, 2017–2024 (USD Million)
Table 25 In Vitro Toxicology Testing Market for Cell Culture Technologies, By Country, 2017–2024 (USD Million)
Table 26 In Vitro Toxicology Testing Market for High-Throughput Technologies, By Country, 2017–2024 (USD Million)
Table 27 In Vitro Toxicology Testing Market for Toxicogenomics, By Country, 2017–2024 (USD Million)
Table 28 In Vitro Toxicology Testing Market, By Industry, 2017–2024 (USD Million)
Table 29 Pharmaceutical & Biopharmaceutical In Vitro Toxicology Testing Market, By Country, 2017–2024 (USD Million)
Table 30 Cosmetic & Household Product In Vitro Toxicology Testing Market, By Country, 2017–2024 (USD Million)
Table 31 Types of Toxicological Tests in the Food Industry
Table 32 Food In Vitro Toxicology Testing Market, By Country, 2017–2024 (USD Million)
Table 33 Chemical In Vitro Toxicology Testing Market, By Country, 2017–2024 (USD Million)
Table 34 In Vitro Toxicology Testing Market, By Method, 2017–2024 (USD Million)
Table 35 In Vitro Toxicology Testing Market for Cellular Assays, By Country, 2017–2024 (USD Million)
Table 36 In Vitro Toxicology Testing Market for Biochemical Assays, By Country, 2017–2024 (USD Million)
Table 37 In Vitro Toxicology Testing Market for in Silico Models, By Country, 2017–2024 (USD Million)
Table 38 In Vitro Toxicology Testing Market for EX Vivo Models, By Country, 2017–2024 (USD Million)
Table 39 In Vitro Toxicology Testing Market, By Region, 2017–2024 (USD Million)
Table 40 Europe: In Vitro Toxicology Testing Market, By Country, 2017–2024 (USD Million)
Table 41 Europe: In Vitro Toxicology Testing Market, By Product & Service, 2017–2024 (USD Million)
Table 42 Europe: In Vitro Toxicology Testing Assays Market, By Type, 2017–2024 (USD Million)
Table 43 Europe: In Vitro Toxicology Testing Market, By Toxicity Endpoint & Test, 2017–2024 (USD Million)
Table 44 Europe: In Vitro Toxicology Testing Market, By Technology, 2017–2024 (USD Million)
Table 45 Europe: In Vitro Toxicology Testing Market, By Industry, 2017–2024 (USD Million)
Table 46 Europe: In Vitro Toxicology Testing Market, By Method, 2017–2024 (USD Million)
Table 47 Germany: In Vitro Toxicology Testing Market, By Product & Service, 2017–2024 (USD Million)
Table 48 Germany: In Vitro Toxicology Testing Assays Market, By Type, 2017–2024 (USD Million)
Table 49 Germany: In Vitro Toxicology Testing Market, By Toxicity Endpoint & Test, 2017–2024 (USD Million)
Table 50 Germany: In Vitro Toxicology Testing Market, By Technology, 2017–2024 (USD Million)
Table 51 Germany: In Vitro Toxicology Testing Market, By Industry, 2017–2024 (USD Million)
Table 52 Germany: In Vitro Toxicology Testing Market, By Method, 2017–2024 (USD Million)
Table 53 UK: In Vitro Toxicology Testing Market, By Product & Service, 2017–2024 (USD Million)
Table 54 UK: In Vitro Toxicology Testing Assays Market, By Type, 2017–2024 (USD Million)
Table 55 UK: In Vitro Toxicology Testing Market, By Toxicity Endpoint & Test, 2017–2024 (USD Million)
Table 56 UK: In Vitro Toxicology Testing Market, By Technology, 2017–2024 (USD Million)
Table 57 UK: In Vitro Toxicology Testing Market, By Industry, 2017–2024 (USD Million)
Table 58 UK: In Vitro Toxicology Testing Market, By Method, 2017–2024 (USD Million)
Table 59 France: In Vitro Toxicology Testing Market, By Product & Service, 2017–2024 (USD Million)
Table 60 France: In Vitro Toxicology Testing Assays Market, By Type, 2017–2024 (USD Million)
Table 61 France: In Vitro Toxicology Testing Market, By Toxicity Endpoint & Test, 2017–2024 (USD Million)
Table 62 France: In Vitro Toxicology Testing Market, By Technology, 2017–2024 (USD Million)
Table 63 France: In Vitro Toxicology Testing Market, By Industry, 2017–2024 (USD Million)
Table 64 France: In Vitro Toxicology Testing Market, By Method, 2017–2024 (USD Million)
Table 65 Italy: In Vitro Toxicology Testing Market, By Product & Service, 2017–2024 (USD Million)
Table 66 Italy: In Vitro Toxicology Testing Assays Market, By Type, 2017–2024 (USD Million)
Table 67 Italy: In Vitro Toxicology Testing Market, By Toxicity Endpoint & Test, 2017–2024 (USD Million)
Table 68 Italy: In Vitro Toxicology Testing Market, By Technology, 2017–2024 (USD Million)
Table 69 Italy: In Vitro Toxicology Testing Market, By Industry, 2017–2024 (USD Million)
Table 70 Italy: In Vitro Toxicology Testing Market, By Method, 2017–2024 (USD Million)
Table 71 Spain: In Vitro Toxicology Testing Market, By Product & Service, 2017–2024 (USD Million)
Table 72 Spain: In Vitro Toxicology Testing Assays Market, By Type, 2017–2024 (USD Million)
Table 73 Spain: In Vitro Toxicology Testing Market, By Toxicity Endpoint & Test, 2017–2024 (USD Million)
Table 74 Spain: In Vitro Toxicology Testing Market, By Technology, 2017–2024 (USD Million)
Table 75 Spain: In Vitro Toxicology Testing Market, By Industry, 2017–2024 (USD Million)
Table 76 Spain: In Vitro Toxicology Testing Market, By Method, 2017–2024 (USD Million)
Table 77 RoE: In Vitro Toxicology Testing Market, By Product & Service, 2017–2024 (USD Million)
Table 78 RoE: In Vitro Toxicology Testing Assays Market, By Type, 2017–2024 (USD Million)
Table 79 RoE: In Vitro Toxicology Testing Market, By Toxicity Endpoint & Test, 2017–2024 (USD Million)
Table 80 RoE: In Vitro Toxicology Testing Market, By Technology, 2017–2024 (USD Million)
Table 81 RoE: In Vitro Toxicology Testing Market, By Industry, 2017–2024 (USD Million)
Table 82 RoE: In Vitro Toxicology Testing Market, By Method, 2017–2024 (USD Million)
Table 83 North America: In Vitro Toxicology Testing Market, By Country, 2017–2024 (USD Million)
Table 84 North America: In Vitro Toxicology Testing Market, By Product & Service, 2017–2024 (USD Million)
Table 85 North America: In Vitro Toxicology Testing Assays Market, By Type, 2017–2024 (USD Million)
Table 86 North America: In Vitro Toxicology Testing Market, By Toxicity Endpoint & Test, 2017–2024 (USD Million)
Table 87 North America: In Vitro Toxicology Testing Market, By Technology, 2017–2024 (USD Million)
Table 88 North America: In Vitro Toxicology Testing Market, By Industry, 2017–2024 (USD Million)
Table 89 North America: In Vitro Toxicology Testing Market, By Method, 2017–2024 (USD Million)
Table 90 US: In Vitro Toxicology Testing Market, By Product & Service, 2017–2024 (USD Million)
Table 91 US: In Vitro Toxicology Testing Assays Market, By Type, 2017–2024 (USD Million)
Table 92 US: In Vitro Toxicology Testing Market, By Toxicity Endpoint & Test, 2017–2024 (USD Million)
Table 93 US: In Vitro Toxicology Testing Market, By Technology, 2017–2024 (USD Million)
Table 94 US: In Vitro Toxicology Testing Market, By Industry, 2017–2024 (USD Million)
Table 95 US: In Vitro Toxicology Testing Market, By Method, 2017–2024 (USD Million)
Table 96 Canada: In Vitro Toxicology Testing Market, By Product & Service, 2017–2024 (USD Million)
Table 97 Canada: In Vitro Toxicology Testing Assays Market, By Type, 2017–2024 (USD Million)
Table 98 Canada: In Vitro Toxicology Testing Market, By Toxicity Endpoint & Test, 2017–2024 (USD Million)
Table 99 Canada: In Vitro Toxicology Testing Market, By Technology, 2017–2024 (USD Million)
Table 100 Canada: In Vitro Toxicology Testing Market, By Industry, 2017–2024 (USD Million)
Table 101 Canada: In Vitro Toxicology Testing Market, By Method, 2017–2024 (USD Million)
Table 102 Asia Pacific: In Vitro Toxicology Testing Market, By Country, 2017–2024 (USD Million)
Table 103 Asia Pacific: In Vitro Toxicology Testing Market, By Product & Service, 2017–2024 (USD Million)
Table 104 Asia Pacific: In Vitro Toxicology Testing Assays Market, By Type, 2017–2024 (USD Million)
Table 105 Asia Pacific: In Vitro Toxicology Testing Market, By Toxicity Endpoint & Test, 2017–2024 (USD Million)
Table 106 Asia Pacific: In Vitro Toxicology Testing Market, By Technology, 2017–2024 (USD Million)
Table 107 Asia Pacific: In Vitro Toxicology Testing Market, By Industry, 2017–2024 (USD Million)
Table 108 Asia Pacific: In Vitro Toxicology Testing Market, By Method, 2017–2024 (USD Million)
Table 109 China: In Vitro Toxicology Testing Market, By Product & Service, 2017–2024 (USD Million)
Table 110 China: In Vitro Toxicology Testing Assays Market, By Type, 2017–2024 (USD Million)
Table 111 China: In Vitro Toxicology Testing Market, By Toxicity Endpoint & Test, 2017–2024 (USD Million)
Table 112 China: In Vitro Toxicology Testing Market, By Technology, 2017–2024 (USD Million)
Table 113 China: In Vitro Toxicology Testing Market, By Industry, 2017–2024 (USD Million)
Table 114 China: In Vitro Toxicology Testing Market, By Method, 2017–2024 (USD Million)
Table 115 Japan: In Vitro Toxicology Testing Market, By Product & Service, 2017–2024 (USD Million)
Table 116 Japan: In Vitro Toxicology Testing Assays Market, By Type, 2017–2024 (USD Million)
Table 117 Japan: In Vitro Toxicology Testing Market, By Toxicity Endpoint & Test, 2017–2024 (USD Million)
Table 118 Japan: In Vitro Toxicology Testing Market, By Technology, 2017–2024 (USD Million)
Table 119 Japan: In Vitro Toxicology Testing Market, By Industry, 2017–2024 (USD Million)
Table 120 Japan: In Vitro Toxicology Testing Market, By Method, 2017–2024 (USD Million)
Table 121 India: In Vitro Toxicology Testing Market, By Product & Service, 2017–2024 (USD Million)
Table 122 India: In Vitro Toxicology Testing Assays Market, By Type, 2017–2024 (USD Million)
Table 123 India: In Vitro Toxicology Testing Market, By Toxicity Endpoint & Test, 2017–2024 (USD Million)
Table 124 India: In Vitro Toxicology Testing Market, By Technology, 2017–2024 (USD Million)
Table 125 India: In Vitro Toxicology Testing Market, By Industry, 2017–2024 (USD Million)
Table 126 India: In Vitro Toxicology Testing Market, By Method, 2017–2024 (USD Million)
Table 127 RoAPAC: In Vitro Toxicology Testing Market, By Product & Service, 2017–2024 (USD Million)
Table 128 RoAPAC: In Vitro Toxicology Testing Assays Market, By Type, 2017–2024 (USD Million)
Table 129 RoAPAC: In Vitro Toxicology Testing Market, By Toxicity Endpoint & Test, 2017–2024 (USD Million)
Table 130 RoAPAC: In Vitro Toxicology Testing Market, By Technology, 2017–2024 (USD Million)
Table 131 RoAPAC: In Vitro Toxicology Testing Market, By Industry, 2017–2024 (USD Million)
Table 132 RoAPAC: In Vitro Toxicology Testing Market, By Method, 2017–2024 (USD Million)
Table 133 Latin America: In Vitro Toxicology Testing Market, By Product & Service, 2017–2024 (USD Million)
Table 134 Latin America: In Vitro Toxicology Testing Assays Market, By Type, 2017–2024 (USD Million)
Table 135 Latin America: In Vitro Toxicology Testing Market, By Toxicity Endpoint & Test, 2017–2024 (USD Million)
Table 136 Latin America: In Vitro Toxicology Testing Market, By Technology, 2017–2024 (USD Million)
Table 137 Latin America: In Vitro Toxicology Testing Market, By Industry, 2017–2024 (USD Million)
Table 138 Latin America: In Vitro Toxicology Testing Market, By Method, 2017–2024 (USD Million)
Table 139 Middle East & Africa: In Vitro Toxicology Testing Market, By Product & Service, 2017–2024 (USD Million)
Table 140 Middle East & Africa: In Vitro Toxicology Testing Assays Market, By Type, 2017–2024 (USD Million)
Table 141 Middle East & Africa: In Vitro Toxicology Testing Market, By Toxicity Endpoint & Test, 2017–2024 (USD Million)
Table 142 Middle East & Africa: In Vitro Toxicology Testing Market, By Technology, 2017–2024 (USD Million)
Table 143 Middle East & Africa: In Vitro Toxicology Testing Market, By Industry, 2017–2024 (USD Million)
Table 144 Middle East & Africa: In Vitro Toxicology Testing Market, By Method, 2017–2024 (USD Million)
Table 145 Product & Service Launches, 2017–2019
Table 146 Expansions, 2017–2019
Table 147 Acquisitions, 2017–2019
Table 148 Other Strategies, 2017–2019


List of Figures (43 Figures)

Figure 1 In Vitro Toxicology Testing Market
Figure 2 Research Design
Figure 3 Breakdown of Primary Interviews: By Company Type, Designation, and Region
Figure 4 Market Size Approach
Figure 5 Bottom-Up Approach
Figure 6 Data Triangulation Methodology
Figure 7 In Vitro Toxicology Testing Market, By Product & Service, 2019 vs 2024 (USD Million)
Figure 8 In Vitro Toxicology Testing Market, By Toxicity Endpoint & Test, 2019 vs 2024 (USD Million)
Figure 9 In Vitro Toxicology Testing Market, By Technology, 2019 vs 2024 (USD Million)
Figure 10 In Vitro Toxicology Testing Market, By Industry, 2019 vs 2024 (USD Million)
Figure 11 In Vitro Toxicology Testing Market, By Method, 2019 vs 2024 (USD Million)
Figure 12 Geographic Analysis: In Vitro Toxicology Testing Market
Figure 13 Opposition to Animal Testing is A Major Factor Driving Market Growth
Figure 14 Cellular Assays Accounted for the Largest Share of the APAC In Vitro Toxicology Testing Market in 2018
Figure 15 China Shows the Highest Revenue Growth During the Forecast Period
Figure 16 Europe Will Continue to Dominate the In Vitro Toxicology Testing Market in 2024
Figure 17 Developing Markets to Register A Higher Growth Rate in the Forecast Period
Figure 18 In Vitro Toxicology Testing Market: Drivers, Restraints, Opportunities, and Challenges
Figure 19 Supply Chain Analysis: In Vitro Toxicology Testing Market
Figure 20 Consumables to Dominate the In Vitro Toxicology Testing Market During the Forecast Period
Figure 21 Organ Toxicity Testing to Register the Highest Growth in the In Vitro Toxicology Testing Market During the Forecast Period
Figure 22 Toxicogenomics Segment to Register the Highest Growth During the Forecast Period
Figure 23 Pharmaceuticals & Biopharmaceuticals to Command the Largest Share of the Market During the Forecast Period
Figure 24 In Silico Models to Register the Highest Growth During the Forecast Period
Figure 25 In Vitro Toxicology Testing Market: Geographic Snapshot (2018)
Figure 26 Europe: In Vitro Toxicology Testing Market Snapshot
Figure 27 Total Number of Clinical Trials: Global vs North America (2017)
Figure 28 North America: In Vitro Toxicology Testing Market Snapshot
Figure 29 Asia Pacific: In Vitro Toxicology Testing Market Snapshot
Figure 30 Key Growth Strategies Adopted By Market Players From 2017 to August 2019
Figure 31 In Vitro Toxicology Testing Market Share, By Key Player, 2018
Figure 32 In Vitro Toxicology Testing Market: Competitive Leadership Mapping (2018)
Figure 33 Thermo Fisher Scientific, Inc.: Company Snapshot (2018)
Figure 34 Merck KGaA: Company Snapshot (2018)
Figure 35 Eurofins Scientific Se: Company Snapshot (2018)
Figure 36 GE Healthcare: Company Snapshot (2018)
Figure 37 Laboratory Corporation of America Holdings: Company Snapshot (2018)
Figure 38 Charles River Laboratories International, Inc.: Company Snapshot (2018)
Figure 39 SGS S.A.: Company Snapshot (2018)
Figure 40 Bio-Rad Laboratories, Inc.: Company Snapshot (2018)
Figure 41 Qiagen N.V.: Company Snapshot (2018)
Figure 42 Evotec AG: Company Snapshot (2018)
Figure 43 Catalent, Inc.: Company Snapshot (2018)

In this report, the global market for in vitro toxicology testing was arrived at after data triangulation from two different approaches as mentioned below. After completion of each approach, a weighted average of the two approaches was taken based on the level of assumptions used in each approach.

Secondary Research

This research study involved the use of comprehensive secondary sources; directories; databases such as Dun & Bradstreet, Bloomberg Businessweek, and Factiva; white papers; annual reports; and companies’ house documents. Secondary research was used to identify and collect information for this extensive, technical, market-oriented, and commercial study of the global in vitro toxicity testing market. It was also used to obtain important information about the top players, market classification, and segmentation according to industry trends to the bottom-most level, geographic markets, key developments related to market, and technology perspectives. A database of the key industry leaders was also prepared using secondary research.

Primary Research

In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources from the supply side include industry experts such as CEOs, vice presidents, marketing directors, technology and innovation directors, and related key executives from various key companies and organizations operating in the in vitro toxicology testing market. Primary sources from the demand side include scientists/researchers from academic & research institutes and government & private laboratories.

Primary research was conducted to validate the market segmentation, identify key players in the market, and gather insights on key industry trends and key market dynamics. A breakdown of the primary respondents is provided below:

In Vitro Toxicity Testing Market, by Region, 2022 (USD Billion)

To know about the assumptions considered for the study, download the pdf brochure

Market Size Estimation

The market size estimates and forecasts provided in this study are derived through a mix of the bottom-up approach (segmental analysis of major segments) and top-down approach (assessment of utilization/adoption/penetration trends, by product and service segment along with the technology, toxicity endpoint & tests, industry, method, and region).

Data Triangulation

After arriving at the market size, the total in vitro toxicology testing market was divided into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics for all segments & subsegments, data triangulation, and market breakdown procedures were employed, wherever applicable.

Objectives of the Study

  • To define, describe, segment, and forecast the global in vitro toxicology testing the market by product & service, technology, toxicity endpoint & test, industry, method, and region
  • To provide detailed information about the factors influencing market growth (such as drivers, restraints, opportunities, and challenges)
  • To analyze micromarkets1 with respect to individual growth trends, prospects, and contributions to the overall market
  • To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
  • To forecast the size of the market in five main regions along with their respective key countries, namely, North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa
  • To profile key players in the global in-vitro toxicology testing market and comprehensively analyze their core competencies2 and market shares
  • To track and analyze competitive developments, such as acquisitions, new product launches, expansions, collaborations, and R&D activities of the leading players in the in vitro toxicology testing market
  • To benchmark players within the market using the "Competitive Leadership Mapping" framework, which analyzes market players on various parameters within the broad categories of business and product strategy

Available Customizations

With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to 5)

Geographic Analysis

  • Further breakdown of the Rest of Asia Pacific in vitro toxicology testing market into South Korea, Australia, New Zealand, and others
  • Further breakdown of the Rest of Europe market into Switzerland, Belgium, Russia, the Netherlands, and others
Report Code
BT 2373
Published ON
Sep, 2019
Choose License Type
BUY NOW
  • SHARE
X
Request Customization
Speak to Analyst
Speak to Analyst
OR FACE-TO-FACE MEETING
PERSONALIZE THIS RESEARCH
  • Triangulate with your Own Data
  • Get Data as per your Format and Definition
  • Gain a Deeper Dive on a Specific Application, Geography, Customer or Competitor
  • Any level of Personalization
REQUEST A FREE CUSTOMIZATION
LET US HELP YOU!
  • What are the Known and Unknown Adjacencies Impacting the In-Vitro Toxicology/Toxicity Testing Market
  • What will your New Revenue Sources be?
  • Who will be your Top Customer; what will make them switch?
  • Defend your Market Share or Win Competitors
  • Get a Scorecard for Target Partners
REQUEST A FREE WORKSHOP
ADJACENT MARKETS
REQUEST BUNDLE REPORTS
ONLINE CHAT
+1-888-600-6441
  • Call Us
  • +1-888-600-6441 (Corporate office hours)
  • +1-888-600-6441 (US/Can toll free)
  • +44-800-368-9399 (UK office hours)
CONNECT WITH US
ABOUT TRUST ONLINE
© MarketsandMarkets Research Private Ltd. All rights reserved
...

Digital Virtual Assistant - MarketsandMarkets

...

Digital Virtual Assistant - MarketsandMarkets

Home